New Jersey A 2544: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Status: Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee (as of 2022-02-14)

State: New Jersey · Session: 220 · Bill: A 2544

Subjects: HEALTH INSUR, PHARMACEUTIC

Sponsors: Murphy, Carol A.

View New Jersey A 2544 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.